A phase I dose escalation study of oral c-MET inhibitor...

Annals of Oncology 2014 / 07 Vol. 25; Iss. 7

A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors

Pant, S., Saleh, M., Bendell, J., Infante, J. R., Jones, S., Kurkjian, C. D., Moore, K. M., Kazakin, J., Abbadessa, G., Wang, Y., Chen, Y., Schwartz, B., Camacho, L. H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu157
Date:
July, 2014
File:
PDF, 107 KB
english, 2014
Conversion to is in progress
Conversion to is failed